Back to top
more

Aphria Inc. (APHA)

(Delayed Data from NYSE)

$6.94 USD

6.94
5,631,062

-0.19 (-2.66%)

Updated May 3, 2019 04:02 PM ET

After-Market: $7.00 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Abbott Stock Down on Urgent Field Safety Notice for TactiCath

Abbott (ABT) also mentions certain guidelines related to product return, reporting, and customer assistance.

LabCorp's New Website Offers Patients Coronavirus Trial Details

LabCorp's (LH) Covance business benefits from collaborations with leading pharmaceutical and biotechnology companies.

Here's Why You Should Retain Ecolab in Your Portfolio Now

Investor confidence is high on Ecolab (ECL) stock, thanks to solid prospects.

Here's Why You Should Hold on to Teleflex (TFX) Stock for Now

Investors continue to be optimistic about Teleflex (TFX) on robust segmental and geographical growth.

Here's Why You Should Add Hologic (HOLX) to Your Portfolio

Investors continue to be optimistic about Hologic (HOLX) on robust segmental growth and regulatory approvals.

Why You Should Retain PerkinElmer (PKI) in Your Portfolio

PerkinElmer (PKI) continues to gain traction from strong international presence and robust product portfolio.

Change Healthcare (CHNG) Q4 Earnings, Revenues Top Estimates

Change Healthcare's (CHNG) fiscal fourth-quarter results benefit from solid performance across the Network Solutions segment and higher revenues.

Amedisys (AMED) Broadens Hospice Base With AseraCare Buyout

Amedisys (AMED) expects AseraCare business to add greater scale to its existing nationwide network.

Bruker Rides on PCI Sales, Coronavirus-Led Supply Issues Hurt

Bruker (BRKR) expects a rise in sales within life science, biopharma and basic medical research, as well as in infectious disease diagnostics due to the pandemic.

HealthEquity (HQY) Q1 Earnings and Revenues Miss Estimates

HealthEquity (HQY) witnessed strong growth in Service, Custodial and Interchange segments in Q1.

ABIOMED's (ABMD) Impella RP Receives FDA's EUA Clearance

This regulatory approval is expected to boost ABIOMED's (ABMD) Impella product portfolio.

Boston Scientific (BSX) Launches Monitoring Tool Post FDA Nod

Boston Scientific (BSX) introduces tool for local measurement and visualization of tissue response to RF ablation treatment in the United States.

Cerner & NCHC Alliance to Boost Behavioral Health Technology

Cerner (CERN) has been selected by NCHC to implement its EHR across three multi-specialty facilities.

Medtronic Alters ECMO Therapy on New FDA Rules for Coronavirus

Medtronic (MDT), in response to the FDA's new guidance due to the coronavirus-led health emergency, has made temporary alterations to its cardiopulmonary product indications for use in ECMO therapy.

Tandem Diabetes Rides on Control-IQ Amid Coronavirus Crisis

Strong domestic pump sales and international expansion boosts sales of Tandem Diabetes (TNDM).

Here's Why You Should Hold on to Tandem Diabetes Stock for Now

Investors continue to be optimistic about Tandem Diabetes (TNDM) on robust pump sales and international growth.

NextGen (NXGN) Earnings and Revenues Beat Estimates in Q4

NextGen's (NXGN) fiscal fourth-quarter 2020 results gain from strong Recurring revenues.

QIAGEN Sales Grow on Coronavirus Solutions Ahead of Selloff

QIAGEN (QGEN) ramps up production capacity of solutions currently being used for testing purposes.

Here's Why You Should Add QIAGEN (QGEN) to Your Portfolio

Investors continue to be optimistic about QIAGEN (QGEN) on robust segmental and geographical growth.

Thermo Fisher (TMO) Partners With CSL to Expand Pharma Arm

Thermo Fisher (TMO), through its alliance with CSL, expands Pharma Services arm to meet the rising demand for biologic therapies.

Here's Why You Should Add Accuray to Your Portfolio Now

Investor confidence is high on Accuray (ARAY) stock, thanks to solid prospects.

Cooper Companies (COO) to Post Q2 Earnings: What's in Store?

Cooper Companies' (COO) fiscal second-quarter performance is likely to reflect better-than-expected performance at CVI and CSI.

Quest Diagnostics' Self-Collection Coronavirus Kit Gets EUA

This kit by Quest Diagnostics (DGX) is suitable for use in children supervised by an adult.

Here's Why You Should Add DexCom (DXCM) to Your Portfolio

DexCom (DXCM) continues to gain traction from strong international presence and robust product portfolio.

LabCorp Partners With Medable to Expand Technology Ecosystem

LabCorp (LH) expands technology ecosystem to accelerate the adoption of decentralized clinical trials by collaborating with Medable.